Advertisement
Loading...

Novozymes A/S

NVZMYā€¢PNK
Basic Materials
Chemicals - Specialty
$59.29
$-0.18(-0.30%)
U.S. Market opens in 0h 30m

Novozymes A/S (NVZMY) Stock Overview

Explore Novozymes A/Sā€™s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap27.6B
P/E Ratio39.35
EPS (TTM)$1.51
ROE0.06%
Fundamental Analysis

AI Price Forecasts

1 Month$63.66
3 Months$70.33
1 Year Target$72.55

NVZMY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Novozymes A/S (NVZMY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 46.32, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $72.55.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 39.35 and a market capitalization of 27.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.52%
5-Day Change
-1.66%
1-Month Change
-2.57%
3-Month Change
-6.85%
6-Month Change
-9.36%
Year-to-Date (YTD) Change
-7.01%
1-Year Change
-10.36%
3-Year Change
10.83%
5-Year Change
-18.91%
All-Time (Max) Change
242.96%

Contact Information

https://www.novozymes.com
45 44 46 00 00
Krogshoejvej 36, Bagsvaerd, NaN, 2880

Company Facts

10,582 Employees
IPO DateJan 20, 2010
CountryDK
Actively Trading

Frequently Asked Questions